Oxytocin and the relationship between doctor and patient.

Phase 1

Active, not recruiting

• Conditions: Healthy individuals; Therapeutic area: Psychiatry and Psychology [F] - Psychological processes [F02]

• Registration Number: EUCTR2018-004081-34-NL

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-16
• Last Update Posted: 10 December 2019

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: Not specified
• Target Recruitment: 76

Inclusion Criteria

Healthy, male subjects aged 18 to 35 years

Subjects must be in good general health

Refrain from alcohol/smoking/caffeine/drugs 24 hrs before the experiment

Refrained from food/drinks (except water) and intensive exercise two hours before the administration of oxytocin

Previous experience with healthcare system, in order to ensure that the subject is able to put himself in the role of a patient

Subjects must be able to communicate well with the investigator in Dutch, to understand and comply with the requirements of the study, and understand and sign the written informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 76
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Known hypersensitivity to oxytocin or to any of the excipients of oxytocin or placebo

Participants who did not abstain from alcohol/smoking/caffeine/drugs 24 hrs before the experiment

Participants who did not abstain from food/drinks (except water) and intensive exercise two hours before the administration of oxytocin

Participants who did not meet the above specified inclusion criteria

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified